344 related articles for article (PubMed ID: 11011445)
21. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis of cancer of the prostate by determining the blood levels of specific prostatic antigen, rectal examination, and transrectal echography].
Isa Kroon WA; Robles JE; de Castro F; Rosell D; Abad JI; Zudaire JJ; Berián JM
Actas Urol Esp; 1993 Jun; 17(6):341-5; discussion 345-6. PubMed ID: 7690176
[TBL] [Abstract][Full Text] [Related]
23. The value of endorectal MRI in the early diagnosis of prostate cancer.
Comet-Batlle J; Vilanova-Busquets JC; Saladié-Roig JM; Gelabert-Mas A; Barceló-Vidal C
Eur Urol; 2003 Aug; 44(2):201-7; discussion 207-8. PubMed ID: 12875939
[TBL] [Abstract][Full Text] [Related]
24. Clinical usefulness of free PSA in early detection of prostate cancer.
Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
[TBL] [Abstract][Full Text] [Related]
25. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.
Scattoni V; Roscigno M; Raber M; Montorsi F; Da Pozzo L; Guazzoni G; Freschi M; Rigatti P
Eur Urol; 2003 Oct; 44(4):407-14. PubMed ID: 14499673
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
[TBL] [Abstract][Full Text] [Related]
27. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
28. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
[TBL] [Abstract][Full Text] [Related]
29. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels.
Arai Y; Maeda H; Ishitoya S; Okubo K; Okada T; Aoki Y
J Urol; 1997 Sep; 158(3 Pt 1):861-4. PubMed ID: 9258099
[TBL] [Abstract][Full Text] [Related]
31. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels.
Cookson MS; Floyd MK; Ball TP; Miller EK; Sarosdy MF
J Urol; 1995 Sep; 154(3):1070-3. PubMed ID: 7543601
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.
Bazinet M; Meshref AW; Trudel C; Aronson S; Péloquin F; Nachabe M; Bégin LR; Elhilali MM
Urology; 1994 Jan; 43(1):44-51; discussion 51-2. PubMed ID: 7506853
[TBL] [Abstract][Full Text] [Related]
33. Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model.
Catalona WJ; Partin AW; Finlay JA; Chan DW; Rittenhouse HG; Wolfert RL; Woodrum DL
Urology; 1999 Aug; 54(2):220-4. PubMed ID: 10443714
[TBL] [Abstract][Full Text] [Related]
34. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
35. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
Crawford ED; Leewansangtong S; Goktas S; Holthaus K; Baier M
Prostate; 1999 Mar; 38(4):296-302. PubMed ID: 10075009
[TBL] [Abstract][Full Text] [Related]
36. [Early diagnosis of prostatic cancer with digital rectal examination, PSA determination, and endorectal echography. Correlations with the morphologic diagnosis in 200 consecutive cases].
Voisin E; Piaton E; Rivain T; Duco F
Prog Urol; 1992 Dec; 2(6):973-9. PubMed ID: 1284556
[TBL] [Abstract][Full Text] [Related]
37. [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].
Martínez Jabaloyas JM; García Morata F; Villamón Fort R; Pastor Hernández F; Gil Salom M; García Sisamón F
Actas Urol Esp; 2003 Jun; 27(6):442-9. PubMed ID: 12918151
[TBL] [Abstract][Full Text] [Related]
38. [Role of rectal exploration, suprapubic and transrectal prostatic ultrasonography, and PSA in the diagnosis and follow-up of prostatic carcinoma].
Speranza I; Bianco V; Banci M; Muià R; Gianni W; Bacciu O; Vecchione A; Marchei P
Minerva Med; 1998; 89(7-8):267-75. PubMed ID: 9824988
[TBL] [Abstract][Full Text] [Related]
39. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
[TBL] [Abstract][Full Text] [Related]
40. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
